We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Physicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients.
- Authors
Breccia, Massimo; Baccarani, Michele; Rosti, Gianantonio; Cottone, Francesco; Cannella, Laura; Guilhot, François; Vignetti, Marco; Efficace, Fabio
- Abstract
We investigated factors that physicians consider of most importance in the selection of second line tyrosine kinase inhibitors treatments (TKIs) in chronic myeloid leukemia patients (CML).
- Subjects
PHYSICIANS' attitudes; MYELOID leukemia; NILOTINIB; DASATINIB; PROTEIN-tyrosine kinases; PATIENTS
- Publication
Health & Quality of Life Outcomes, 2017, Vol 15, p1
- ISSN
1477-7525
- Publication type
letter
- DOI
10.1186/s12955-017-0788-4